Atropine (injection)

🧮 Dose calculator

Symptomatic bradycardia · Regimen source: FDA Atropine inj. · 2.2, Table 1

• • Repeat every 1–2 h; titrate to heart rate, PR interval, blood pressure and symptoms. In coronary artery disease limit total dose to 0.03–0.04 mg/kg. FDA Atropine inj. · 2.2, Table 1FDA Atropine inj. · 2.4

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Atropine inj. · 8.1

  “Risk Summary There are risks to the mother and fetus associated with untreated severe or life-threatening muscarinic events (see Clinical Considerations ) .”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Atropine inj. · 8.2

  “Risk Summary Trace amounts of atropine have been reported in human milk.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Atropine inj. · 8.4

  “Recommendations for use in pediatric patients are not based on clinical trials.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Atropine inj. · 8.5

  “In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.